The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

According to the latest market study published by Vyansa Intelligence, the Global Animal Regenerative Therapies Market is projected to grow at a CAGR of around 12.99% during 2026–2032. The market ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...

Suggested Citation: "1. Introduction." National Research Council. 2002. Animal Biotechnology: Science-Based Concerns. Washington, DC: The National Academies Press. doi: 10.17226/10418. Agricultural ...

A new innovation agenda released by the Food and Drug Administration's Center for Veterinary Medicine outlines how CVM plans to address hot-button issues such as approvals of zootechnical feed ...

Biotechnology is a branch of science that integrates natural sciences, including the biological study of animal and plants, with engineering. Animal and plant biotechnology applies molecular biology ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...

TOKYO, March 9, 2026 /PRNewswire/ -- bitBiome, Inc., a pioneer in the discovery, design, and engineering of novel bio-manufactured products, today announced a joint development and collaboration ...

Growing Concern Over the Use of ADCs in Polymeric Materials Polymeric materials have been widely used in bioprocessing for more than a decade. Disposable processing products manufactured from plastic ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...